Skip to main content
. 2011 Jun 13;26(9):2316–2321. doi: 10.1093/humrep/der181

Figure 1.

Figure 1

Profile of a Phase IV clinical trial to investigate the efficacy and safety of a LNG enteric-coated tablet as an OTC drug for EC.